• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ataxia-telangiectasia mutated is required for the development of protective immune memory after influenza A virus infection

tetano

Editor, Senior Moderator
Am J Physiol Lung Cell Mol Physiol. 2019 Sep 11. doi: 10.1152/ajplung.00031.2019. [Epub ahead of print]
[h=1]Ataxia-telangiectasia mutated is required for the development of protective immune memory after influenza A virus infection.[/h] Warren R[SUP]1[/SUP], Domm W[SUP]2[/SUP], Yee M[SUP]3[/SUP], Campbell A[SUP]4[/SUP], Malone J[SUP]2[/SUP], Wright T[SUP]2[/SUP], Mayer-Proschel M[SUP]5[/SUP], O'Reilly MA[SUP]2[/SUP].
[h=3]Author information[/h] 1 Microbiology and Immunology, The University of Rochester, United States. 2 Pediatrics, The University of Rochester, United States. 3 Pediatrics, University of Rochester, United States. 4 Biomedical Genetics, The University of Rochester, United States. 5 University of Rochester.

[h=3]Abstract[/h] Ataxia-telangiectasia (A-T) is a neurodegenerative disorder affecting approximately 1 in 40,000 to 100,000 children caused by mutations in the A-T mutated(ATM) gene. Recurrent respiratory infections are a common and challenging co-morbidity often leading to the development of bronchiectasis in A-T individuals. The role of ATM in development of immune memory in response to recurrent respiratory viral infections is not well understood. Here, we infect wildtype (WT) and Atm-null mice with influenza A virus (IAV; HKx31, H3N2) and interrogate the immune memory with secondary infections designed to challenge the B cell memory response with homologous infection (HKx31) and T cell memory response with heterologous infection (PR8, H1N1). Although Atm-null mice survived primary and secondary infections, they lost more weight than WT mice during secondary infections. This enhanced morbidity to secondary infections was not attributed to failure to effectively clear virus during the primary IAV infection. Instead, Atm-null mice developed persistent peribronchial inflammation characterized in part by clusters of B220+ B cells. Additionally, Atm-null mice had significantly lower levels of select serum antibodies to IAV hemagglutinin (HA)-specific compared to WT mice. These findings reveal that Atm is required to mount a proper memory response to a primary IAV infection implying that vaccination of A-T children by itself may not be sufficiently protective against respiratory viral infections.


[h=4]KEYWORDS:[/h] ataxia telangiectasia; immune memory; influenza A virus; recurrent infections; vaccination

PMID: 31509427 DOI: 10.1152/ajplung.00031.2019
 
Back
Top Bottom